MICB gene expression on peripheral blood mononuclear cells and susceptibility to multiple sclerosis in North of Iran

Iranian Journal of Allergy, Asthma and Immunology

Volumn 10, Issue 4, 2011, Pages 261-265

  Abediankenari, Saeid ^a   Yousefzadeh, Yousef ^a   Majidi, Mohammad ^a   Ghasemi, Maryam ^a   Nasehi, Mohammad Mahdi ^a   Ghaffari, Javad ^a   Saravi, Reza Habibi ^b   Abedini, Mahmoud ^b   Elyasi, Mitra ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Education and Research   (Iran)

Author keywords

MICA; MICB; Multiple sclerosis

Indexed keywords

BETA ACTIN; BETA1A INTERFERON; COMPLEMENTARY DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 RELATED GENE A PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 RELATED GENE B PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IRAN; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ADULT; DISEASE SUSCEPTIBILITY; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRAN; LEUKOCYTES, MONONUCLEAR; MALE; MULTIPLE SCLEROSIS;

EID: 84455171314     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Rizvi S. Multiple sclerosis: current and future treatment options. Endocr Metab Immune Disord Drug Targets 2007; 7(4):292-9.
2. Boiko AN, Favorova OO. Multiple sclerosis: molecular and cellular mechanisms. Mol Biol (Mosk) 1995; 29(4):727-49.
3. Mechelli R, Annibali V, Ristori G, Vittori D, Coarelli G, Salvetti M. Multiple sclerosis etiology: beyond genes and environment. Expert Rev Clin Immunol 2010; 6(3):481-90.
4. Ramagopalan SV, Ebers GC. Multiple sclerosis: major histocompatibility complexity and antigen presentation. Genome Med 2009; 1(11):105.
5. Yasuoka H, Okazaki Y, Kawakami Y, Hirakata M, Inoko H, Ikeda Y, et al. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease. Arthritis Rheum 2004; 50(11):3658-62. (Pubitemid 39488694)
6. Shojima J, Tanaka G, Keicho N, Tamiya G, Ando S, Oka A, et al. Identification of MICA as a susceptibility gene for pulmonary Mycobacterium avium complex infection. J Infect Dis 2009; 199(11):1707-15.
7. Kohga K, Takehara T, Tatsumi T, Ishida H, Miyagi T, Hosui A, et al. Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9. Hepatology 2010; 51(4):1264-73.
8. Groh V, Sleinle A, Bauer S, Spies T. Recognition of stress induced MHC molecules by intestinal epithelial γ§T cells. Science 1998; 279(5357):1737-40. (Pubitemid 28164472)
9. Bauer S, Groh V, Wu J, Steinle A, Philips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285(5428):727-9.
10. Pay S, Simsek I, Erdem H, Dinç A. Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 2007; 27(5):417-24. (Pubitemid 46294993)
11. Fuertes MB, Girart MV, Molinero LL, Domaica CI, Rossi LE, Barrio MM, et al. Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity. J Immunol 2008; 180(7):4606-14.
12. Beetz S, Marischen L, Kabelitz D, Wesch D. Human gamma delta T cells: candidates for the development of immunotherapeutic strategies. Immunol Res 2007; 37(2):97-111. (Pubitemid 47344127)
13. Groh V, Bruhl A, El-Gabalawi H, Nelson JL, Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rhomatoid arthritis. Proc Natl Acad Sci USA 2003; 100(16):9452-7. (Pubitemid 37033949)
14. Ogasawara K, Hamerman JA, Ehrlich LR, Bour-Jordan H, Sanlamaria P, Bluestone JA, et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004; 20(6):757-67. (Pubitemid 38757445)
15. Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004; 21(3):367-77. (Pubitemid 39208338)
16. Bauer S, Groh V, Wu J, Steinle A, Philip JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible in MICA. Science 1999; 285(5428):727-9.
17. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumor-associated expression and recognition by tumor-derived γ§T cells of MICA and MICB. Proc Natl Acad Sci USA 1999; 96(12):6879-84. (Pubitemid 29274978)
18. Fernandez-Morera JL, Rodriguez-Rodero S, Lahoz C, Tunon A, Astudillo A, Garcia-Suarez O, et al. Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis. Hum immunol 2005; 69:235-40.
19. Jinushi M, Takehara T, Tatsumi T, Kanto T, Groh V, spies T, et al. Expression and role of MICA and MICB in human hepatocellular carcinoma and their regulation by retinoic acid. Int J Cancer 2003; 104(3):354-61. (Pubitemid 36249818)